Stay updated on Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Sign up to get notified when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The revision label at the bottom of the page updated from v3.6.5 to v3.6.6, reflecting a new frontend/backend release without changes to the study details.
    Difference
    0.0%
    Check dated 2026-09-01T17:47:33.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing v3.6.4. This appears to be a small backend or formatting update rather than a substantive change to study details.
    Difference
    0.0%
    Check dated 2026-08-11T16:54:27.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The revision label in the page footer was updated from v3.6.3 to v3.6.4. This indicates a minor platform/template update and does not affect study content or functionality.
    Difference
    0.0%
    Check dated 2026-07-28T05:27:46.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page now displays a new Revision: v3.6.3 and removes Revision: v3.6.2, updating the site's versioning metadata.
    Difference
    0.0%
    Check dated 2026-07-06T10:52:53.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer minor version of the documentation. This reflects a small update to the page metadata rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-06-28T08:18:31.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Recruitment is now closed for this study, as indicated by 'No longer looking for participants.' The page also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the labeling of the Intervention/Treatment section along with a Revision: v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-14T03:35:51.000Z thumbnail image

Stay in the know with updates to Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.